Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-13
2008-12-16
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S019300, C530S300000, C530S331000
Reexamination Certificate
active
07465710
ABSTRACT:
This invention relates generally to dipeptides and tripeptides and to methods for pharmaceutical treatment of mammals using analogs of such dipeptides and tripeptides. More specifically, the invention relates to tripeptides and their analogs, to pharmaceutical compositions containing such dipeptides and tripeptides and to methods of treatment of mammals using such dipeptides and tripeptides. In addition, the invention relates to methods of treatment of mammals using such dipeptides and tripeptides for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm.
REFERENCES:
patent: 3842067 (1974-10-01), Sarantakis
patent: 3862925 (1975-01-01), Sarantakis et al.
patent: 3972859 (1976-08-01), Fujino et al.
patent: 4105603 (1978-08-01), Vale, Jr. et al.
patent: 4244946 (1981-01-01), Rivier et al.
patent: 4297346 (1981-10-01), Rips et al.
patent: 4415558 (1983-11-01), Vale, Jr. et al.
patent: 4490364 (1984-12-01), Rivier et al.
patent: 4839343 (1989-06-01), Waeber et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 5270302 (1993-12-01), Shiosaki et al.
patent: 5328899 (1994-07-01), Boublik et al.
patent: 5410018 (1995-04-01), Spindel et al.
patent: 5993843 (1999-11-01), Sakurada et al.
patent: 6235718 (2001-05-01), Balasubramanium et al.
patent: 6737408 (2004-05-01), Balasubramanium et al.
patent: 288985 (1988-04-01), None
patent: 0268297 (1988-05-01), None
patent: 0381340 (1990-08-01), None
patent: WO 9103494 (1991-03-01), None
A. Balasubramaniam et al.,Characterization of Neuropeptide Y Binding Sites in Rat Cardiac Ventricular Membranes, Peptides, vol. 11, 1990, pp. 545-550.
A. Balasubramanium et al.,Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropeptide Y, Biochimica et Biophysica Acta, vol. 997, 1989, pp. 176-181.
Elizabeth N. Barnes et al.,The Fine Structure of Continuous Human Neuroblastoma Lines SK-N-SH, SK-N-BE(2), and SK-N-MC., In Vitro, vol.17, No. 7, Jul. 1981, pp. 619-631.
Ulrich Bickel et al.,Synthesis and Biocativity of Monobiotinylated DALDA: A Mu-Specific Oploid Peptides Designed for Targeted Brain Delivery, Journal of Pharmacology and Experimental Therapeutics, vol. 268, No. 2, 1994, pp. 791-796.
D. Bleakman et al.,Neuropeptide Y Inhibits Ca2 + Influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor, Dept. of Pharmacological and Physiological Sciences, Univerisity of Chicago, Mar. 11, 1991, pp. 1781-1789.
W.T. Chance et al.,Partussis Toxin Inhibits Neuropeptide Y-induced Feading in Rats, Peptides, vol. 10, 1989, pp. 1283-1286.
S.T. Cheung et al.,N-Methylamino acids in peptide synthesis. V. The synthesis of N-tert-butyloxycarbonyl, N-methylamino acids by N-methylation, Can. J. Chem., vol. 55, 1997, pp. 906-910.
William F. Colmers et al.,The Biology of Neuropeptide Y and Related Peptides, Human Press Inc., 1993, pp. 197-239.
David H. Coy et al.,Solid Phase Reductive Alkylation Techniques in Analogues in Peptide Bond and Side-Chain Modification, Tetrahedron, vol. 44, No. 3, 1988, pp. 835-841.
D. De Wied (Ed.),Neuropeptides, Basics and Perspectives, Elsevier Science Publishers, The Netherlands, 1990, Chap. V-IX.
Yvan Dumont et al.,Neuropeptide Y and Neuropeptide Y Receptor Subtypes in Brain and Peripheral Tissues, Progress in Neurobiology, vol. 38, 1992, pp. 125-167.
Jean-Alain Fehrentz et al.,An Efficient Synthesis of Optically Active a-(t-Butoxycarbonylamino)-aidehydes from a-Amino Acids, Communications, Aug. 1983, pp. 676-678.
James F. Flood et al.,Dissociation of the Effects of Neuropeptide Y on Feeding and Memory: Evidence for Pre-and Postsynaptic Mediation, Peptides, vol. 10, 1989, pp. 963-966.
Roger M. Freidinger et al.,Synthesis of 9-Fluorenylmethylozycarbonyl-Protected N-alkyl Amino Acids by Reduction of Oxazolidinones, J. Org. Chem., vol. 48, 1983, pp. 77-81.
Jannie Fuhlendorff et al.,[Leu31, Pro34] Neuropeptide Y: A specific Y1 receptor agonist, Biochemistry, Proc. Natl. Acad. Sci., vol. 87, Jan. 1990, pp. 182-186.
A.R. Gennaro et al. (Eds.),Remington's Pharmaceutical Sciences, Mark Publishing Company, Easton, PA, 1990.
Glover et al.,Conformational studies on the pancreatic polypeptides hormone family, Eur. J. Biochem. vol. 142, 1985, pp. 379-385.
Eric A. Gordon et al.,Characterization of Functional Neuropeptide Y Receptors in a Human Neuroblastoma Cell Line, Journal of Neurochemistry, International Society for Neurochemistry, 1990, pp. 506-513.
E. Gross et al. (Eds.),The Peptides, vol. 1, Academic Press, Inc., New York, London, 1979, 26-52, 125-126, 156-174, 242-260, 293-304, 336-362.
E. Gross et al. (Eds.),The Peptides, vol. 3, Academic Press, Inc., New York, London, 1981, 1-99, 101-136, 203-252.
M. Heilig et al.,Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropyhchiatric illnesses, Acta Psyhciatr. Scand., vol. 82, 1990, 95-114.
M. Heilig et al.,Neuropeptide Y: an overview of central distrubution, funtional aspects, and possible involvement in neuropsychiatric illnesses, Dept. of Psychiatry and Neurochemistry, University of Lund, Lund, Sweden, Mar. 17, 1990, pp. 95-114.
Joseph Hinson et al.,Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms, Brain Research, vol. 446, 1988, pp. 379-382.
IUPAC-IUB Commission on Biochemical Nomenclature A One-Letter Notation for Amino Acid Sequences Tentative Rules, The Journal of Biological Chemistry, vol. 243, No. 13, Jul. 10, 1968, pp. 3557-3359.
Shin-ichi Mihara et al.,Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells, FEBS Letters, vol. 258, No. 1, Dec. 1989, pp. 79-82.
Harvey J. Motutsky et al.,Neuropeptide Y Mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells, Amer. J. of Physiological Society, 1988, pp. E880-E885.
William M. Pardridge et al.,Endorphin Chimeric Peptides: Transport through the Blood-Brain Barrier in Vivo and Cleavage of Disulfide Linkage by Brain, Endocrinology, vol. 126, No. 2, 1990, pp. 977-984.
Marc Rodriguiz et al.,Synthesis and Biological Activites of Pseudopeptide analogues of the C-Terminal Heptapeptide of Cholecystokinin. On the Importance of the Peptide Bonds, J. Med. Chem., vol. 30, 1987, pp. 1366-1373.
Y. Sasaki et al.,Solid Phase Synthesis of Peptides Containing the CH2NH Peptide Bond Isotere, Peptides, vol. 8, 1987, pp. 119-121.
Eberhard Schroder et al.,Methods of Peptide Synthesis, The Peptides, Academic Press, 1965, pp. 72-75.
Thue W. Schwartz et al.,Signal Epitopes in the Three-Dimensional Structure of Neuropeptide Y Interaction with Y1, Y2, and Pancreatic Polypeptide Receptors, Annals of New York Academy of Sciences, vol. 611, 1990, pp. 35-47.
Soren P. Sheikh et al.,Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas, American Physiological Society, 1991, pp. G250-G257.
Soren P. Sheikh et al.,Structural Characterization of Y1 and Y2 Receptors for Neuropeptide Y and Peptide YY by Affinity Cross-linking, J. Biol. Chem, vol. 265, No. 14, May 15, 1990, pp. 8304-8310.
Anders Unden et al.,Neuropeptide Y receptor in the rat brain, Eur. J. Biochem., vol. 145, FEBS 1984, pp. 525-530.
Claes Wahlestedt et al.,Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides, Regulatory Peptides, vol. 13, 1986, pp. 307-318.
Mary W. Walker et al.,1251-Neuropeplife Y and 1251-Peptide YY Bind to Multiple Receptor Sites in Rat Brain, Molecular Pharmacology, vol. 34, Sep. 8, 1988, pp. 779-792.
Anita Westlind-Danielson et al.,Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex, Neuroscience Letters, vol. 74, 1987, pp. 237-242.
J.D. Wilson, M.D. et al.,Harrison's Principles of Internal Medicine, 12th Ed., McGraw-Hill, Inc., New York, NY, 1991, Chap. 15, 65-67, 69, 75-76, 84-86, 151, 182, 185, 190, 196, 301, 316-317, 319, 321-322, 369, 371-372.
Jan M. Lundberg et al.,Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclick AMP formation and calcium antogonist inhibition of yasoconstriction, European
Balasubramanium Ambikaipakan
Chance William T.
Kam Chih-Min
University of Cincinnati
Wood Herron & Evans LLP
LandOfFree
Compounds for control of appetite, blood pressure,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for control of appetite, blood pressure,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for control of appetite, blood pressure,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4033320